SlideShare una empresa de Scribd logo
1 de 9
Carol Andrea Casallas
Residente Farmacología Clínica
1886                 1958                1963             1970-1984                 1995              2005


Boswell-Smith V, et al. Phosphodiesterase inhibitors. British Journal of Pharmacology (2006) 147, S252–S257
Vezzosi D, et al. Phosphodiesterases in endocrine physiology and disease. European Journal of Endocrinology (2011) 165 177–188
α       β          γ

               Adenil Ciclasa

       GMPc            AMPc                                            Enzimas Efectoras

                                                                       Canales Iónicos
                                                   PKA
        5’GMP           5’AMP                                          Transcripción Genética
                                                                            Diferenciación
                                                                            Proliferación

Boswell-Smith V, et al. Phosphodiesterase inhibitors. British Journal of Pharmacology (2006) 147, S252–S257
Vezzosi D, et al. Phosphodiesterases in endocrine physiology and disease. European Journal of Endocrinology (2011) 165 177–188
Son 11Familias:                                       PDE 3                       PDE 4                      PDE 5
   • 3 Selectivos AMPc
                                                  Vasodialtación.             Cel. Inflamatoria           Vasodilatador
   (4,7,8).                                       Broncodilatación            Broncodialtación            Pentoxifilina
   • 3 Selectivos GMPc                            Antiagregación              PDE4 (a4)- PDE7             Sildenafil
   (5,6,9).                                       Inotropico (+)              Teofilina
   • 5 Ambos                                      Milrinone                   Roflumilast
                                                  Cilostazol
   (1,2,3,10,11)




Boswell-Smith V, et al. Phosphodiesterase inhibitors. British Journal of Pharmacology (2006) 147, S252–S257
Vezzosi D, et al. Phosphodiesterases in endocrine physiology and disease. European Journal of Endocrinology (2011) 165 177–188
Boswell-Smith V, et al. Phosphodiesterase inhibitors. British Journal of Pharmacology (2006) 147, S252–S257
Vezzosi D, et al. Phosphodiesterases in endocrine physiology and disease. European Journal of Endocrinology (2011) 165 177–188
Boswell-Smith V, et al. Phosphodiesterase inhibitors. British Journal of Pharmacology (2006) 147, S252–S257
Vezzosi D, et al. Phosphodiesterases in endocrine physiology and disease. European Journal of Endocrinology (2011) 165 177–188
Boswell-Smith V, et al. Phosphodiesterase inhibitors. British Journal of Pharmacology (2006) 147, S252–S257
Vezzosi D, et al. Phosphodiesterases in endocrine physiology and disease. European Journal of Endocrinology (2011) 165 177–188
Boswell-Smith V, et al. Phosphodiesterase inhibitors. British Journal of Pharmacology (2006) 147, S252–S257
Vezzosi D, et al. Phosphodiesterases in endocrine physiology and disease. European Journal of Endocrinology (2011) 165 177–188
Fosfodiesterasas

Más contenido relacionado

Similar a Fosfodiesterasas

Dementias advances in treatment
Dementias advances in treatmentDementias advances in treatment
Dementias advances in treatmentYasir Hameed
 
PDE Phosphodiesterase inhibitors.pdf
PDE Phosphodiesterase inhibitors.pdfPDE Phosphodiesterase inhibitors.pdf
PDE Phosphodiesterase inhibitors.pdfCoreyEasley3
 
CV Robson Harvard-Dec. 2015
CV Robson Harvard-Dec. 2015CV Robson Harvard-Dec. 2015
CV Robson Harvard-Dec. 2015simon robson
 
4th unit drugs for erectile dysfunction
4th unit drugs for erectile dysfunction4th unit drugs for erectile dysfunction
4th unit drugs for erectile dysfunctionNikithaGopalpet
 
4thunit-drugsforerectiledysfunction-201106104139.pdf
4thunit-drugsforerectiledysfunction-201106104139.pdf4thunit-drugsforerectiledysfunction-201106104139.pdf
4thunit-drugsforerectiledysfunction-201106104139.pdfdattesh5049
 
Estevesevolutionofovarianstimulationforart towardsanindividualizedapproach-fi...
Estevesevolutionofovarianstimulationforart towardsanindividualizedapproach-fi...Estevesevolutionofovarianstimulationforart towardsanindividualizedapproach-fi...
Estevesevolutionofovarianstimulationforart towardsanindividualizedapproach-fi...鋒博 蔡
 
Bosentan- Systematic Review
Bosentan- Systematic ReviewBosentan- Systematic Review
Bosentan- Systematic ReviewHaroon Rashid
 
Erectile dysfunction
Erectile dysfunctionErectile dysfunction
Erectile dysfunctionUdr Farouk
 
Improving Success by Tailoring Infertility Treatments - We are all individuals
Improving Success by Tailoring Infertility Treatments - We are all individualsImproving Success by Tailoring Infertility Treatments - We are all individuals
Improving Success by Tailoring Infertility Treatments - We are all individualsSandro Esteves
 
Synthetic peptide as drugs
Synthetic peptide as drugs Synthetic peptide as drugs
Synthetic peptide as drugs 693058
 
Raising Hope for Fading Manhood
Raising Hope for Fading ManhoodRaising Hope for Fading Manhood
Raising Hope for Fading ManhoodSiewhong Ho
 
drugsforurologicaldisorders-180401070647 (1).pdf
drugsforurologicaldisorders-180401070647 (1).pdfdrugsforurologicaldisorders-180401070647 (1).pdf
drugsforurologicaldisorders-180401070647 (1).pdfdattesh5049
 
Erectile dysfunction updates
Erectile dysfunction updatesErectile dysfunction updates
Erectile dysfunction updatesMohamed Elgendy
 

Similar a Fosfodiesterasas (20)

Compounding for Erectile Dysfunction
Compounding for Erectile DysfunctionCompounding for Erectile Dysfunction
Compounding for Erectile Dysfunction
 
Dementias advances in treatment
Dementias advances in treatmentDementias advances in treatment
Dementias advances in treatment
 
PDE Phosphodiesterase inhibitors.pdf
PDE Phosphodiesterase inhibitors.pdfPDE Phosphodiesterase inhibitors.pdf
PDE Phosphodiesterase inhibitors.pdf
 
CV Robson Harvard-Dec. 2015
CV Robson Harvard-Dec. 2015CV Robson Harvard-Dec. 2015
CV Robson Harvard-Dec. 2015
 
Taking the measure of a man
Taking the measure of a manTaking the measure of a man
Taking the measure of a man
 
4th unit drugs for erectile dysfunction
4th unit drugs for erectile dysfunction4th unit drugs for erectile dysfunction
4th unit drugs for erectile dysfunction
 
4thunit-drugsforerectiledysfunction-201106104139.pdf
4thunit-drugsforerectiledysfunction-201106104139.pdf4thunit-drugsforerectiledysfunction-201106104139.pdf
4thunit-drugsforerectiledysfunction-201106104139.pdf
 
Estevesevolutionofovarianstimulationforart towardsanindividualizedapproach-fi...
Estevesevolutionofovarianstimulationforart towardsanindividualizedapproach-fi...Estevesevolutionofovarianstimulationforart towardsanindividualizedapproach-fi...
Estevesevolutionofovarianstimulationforart towardsanindividualizedapproach-fi...
 
Me ja paper 1
Me ja paper 1Me ja paper 1
Me ja paper 1
 
Bosentan- Systematic Review
Bosentan- Systematic ReviewBosentan- Systematic Review
Bosentan- Systematic Review
 
Erectile dysfunction
Erectile dysfunctionErectile dysfunction
Erectile dysfunction
 
Improving Success by Tailoring Infertility Treatments - We are all individuals
Improving Success by Tailoring Infertility Treatments - We are all individualsImproving Success by Tailoring Infertility Treatments - We are all individuals
Improving Success by Tailoring Infertility Treatments - We are all individuals
 
Enablex
EnablexEnablex
Enablex
 
Enablex
EnablexEnablex
Enablex
 
Synthetic peptide as drugs
Synthetic peptide as drugs Synthetic peptide as drugs
Synthetic peptide as drugs
 
Raising Hope for Fading Manhood
Raising Hope for Fading ManhoodRaising Hope for Fading Manhood
Raising Hope for Fading Manhood
 
PoDiaPN Sheet .PDF
PoDiaPN Sheet .PDFPoDiaPN Sheet .PDF
PoDiaPN Sheet .PDF
 
Drugs for Erectile Dysfunction
Drugs for Erectile DysfunctionDrugs for Erectile Dysfunction
Drugs for Erectile Dysfunction
 
drugsforurologicaldisorders-180401070647 (1).pdf
drugsforurologicaldisorders-180401070647 (1).pdfdrugsforurologicaldisorders-180401070647 (1).pdf
drugsforurologicaldisorders-180401070647 (1).pdf
 
Erectile dysfunction updates
Erectile dysfunction updatesErectile dysfunction updates
Erectile dysfunction updates
 

Más de evidenciaterapeutica

Proteccion gastrica en paciente hospitalizado
Proteccion gastrica en paciente hospitalizadoProteccion gastrica en paciente hospitalizado
Proteccion gastrica en paciente hospitalizadoevidenciaterapeutica
 
Composicion cristaloides y coloides
Composicion cristaloides y coloidesComposicion cristaloides y coloides
Composicion cristaloides y coloidesevidenciaterapeutica
 
Diabetes Mellitus Farmacologia Clínica
Diabetes Mellitus Farmacologia ClínicaDiabetes Mellitus Farmacologia Clínica
Diabetes Mellitus Farmacologia Clínicaevidenciaterapeutica
 
Hipertension arterial secundaria 1
Hipertension arterial secundaria 1Hipertension arterial secundaria 1
Hipertension arterial secundaria 1evidenciaterapeutica
 
Paciente intoxicado correlacion clinicoterapeutica
Paciente intoxicado correlacion clinicoterapeuticaPaciente intoxicado correlacion clinicoterapeutica
Paciente intoxicado correlacion clinicoterapeuticaevidenciaterapeutica
 
Hipertension arterial escencial fisiopatologia
Hipertension arterial escencial fisiopatologiaHipertension arterial escencial fisiopatologia
Hipertension arterial escencial fisiopatologiaevidenciaterapeutica
 
Hipertension arterial escencial completa
Hipertension arterial escencial completaHipertension arterial escencial completa
Hipertension arterial escencial completaevidenciaterapeutica
 

Más de evidenciaterapeutica (20)

Crisis hipertensiva Caso Clínico
Crisis hipertensiva Caso ClínicoCrisis hipertensiva Caso Clínico
Crisis hipertensiva Caso Clínico
 
Proteccion gastrica en paciente hospitalizado
Proteccion gastrica en paciente hospitalizadoProteccion gastrica en paciente hospitalizado
Proteccion gastrica en paciente hospitalizado
 
Infección de vías urinarias
Infección de vías urinariasInfección de vías urinarias
Infección de vías urinarias
 
Composicion cristaloides y coloides
Composicion cristaloides y coloidesComposicion cristaloides y coloides
Composicion cristaloides y coloides
 
Calcio antagonistas
Calcio antagonistasCalcio antagonistas
Calcio antagonistas
 
Ulcera peptica cus
Ulcera peptica cusUlcera peptica cus
Ulcera peptica cus
 
Evidencia de falla terapeutica
Evidencia de falla terapeuticaEvidencia de falla terapeutica
Evidencia de falla terapeutica
 
Diabetes Mellitus Farmacologia Clínica
Diabetes Mellitus Farmacologia ClínicaDiabetes Mellitus Farmacologia Clínica
Diabetes Mellitus Farmacologia Clínica
 
Farmacocinetica clinica
Farmacocinetica clinicaFarmacocinetica clinica
Farmacocinetica clinica
 
Hipertension arterial secundaria 1
Hipertension arterial secundaria 1Hipertension arterial secundaria 1
Hipertension arterial secundaria 1
 
Epoc
EpocEpoc
Epoc
 
Dislipidemia
DislipidemiaDislipidemia
Dislipidemia
 
Antidiabéticos orales
Antidiabéticos oralesAntidiabéticos orales
Antidiabéticos orales
 
Paciente intoxicado correlacion clinicoterapeutica
Paciente intoxicado correlacion clinicoterapeuticaPaciente intoxicado correlacion clinicoterapeutica
Paciente intoxicado correlacion clinicoterapeutica
 
Sindromes icterohemorragicos us
Sindromes icterohemorragicos usSindromes icterohemorragicos us
Sindromes icterohemorragicos us
 
Tratamiento del asma y epoc
Tratamiento del asma y epocTratamiento del asma y epoc
Tratamiento del asma y epoc
 
Hipertension arterial escencial fisiopatologia
Hipertension arterial escencial fisiopatologiaHipertension arterial escencial fisiopatologia
Hipertension arterial escencial fisiopatologia
 
Sindrome metabólico
Sindrome metabólicoSindrome metabólico
Sindrome metabólico
 
Hipertension arterial escencial completa
Hipertension arterial escencial completaHipertension arterial escencial completa
Hipertension arterial escencial completa
 
Efectos de la terapia antitbc
Efectos de la terapia antitbcEfectos de la terapia antitbc
Efectos de la terapia antitbc
 

Fosfodiesterasas

  • 1. Carol Andrea Casallas Residente Farmacología Clínica
  • 2. 1886 1958 1963 1970-1984 1995 2005 Boswell-Smith V, et al. Phosphodiesterase inhibitors. British Journal of Pharmacology (2006) 147, S252–S257 Vezzosi D, et al. Phosphodiesterases in endocrine physiology and disease. European Journal of Endocrinology (2011) 165 177–188
  • 3. α β γ Adenil Ciclasa GMPc AMPc Enzimas Efectoras Canales Iónicos PKA 5’GMP 5’AMP Transcripción Genética Diferenciación Proliferación Boswell-Smith V, et al. Phosphodiesterase inhibitors. British Journal of Pharmacology (2006) 147, S252–S257 Vezzosi D, et al. Phosphodiesterases in endocrine physiology and disease. European Journal of Endocrinology (2011) 165 177–188
  • 4. Son 11Familias: PDE 3 PDE 4 PDE 5 • 3 Selectivos AMPc Vasodialtación. Cel. Inflamatoria Vasodilatador (4,7,8). Broncodilatación Broncodialtación Pentoxifilina • 3 Selectivos GMPc Antiagregación PDE4 (a4)- PDE7 Sildenafil (5,6,9). Inotropico (+) Teofilina • 5 Ambos Milrinone Roflumilast Cilostazol (1,2,3,10,11) Boswell-Smith V, et al. Phosphodiesterase inhibitors. British Journal of Pharmacology (2006) 147, S252–S257 Vezzosi D, et al. Phosphodiesterases in endocrine physiology and disease. European Journal of Endocrinology (2011) 165 177–188
  • 5. Boswell-Smith V, et al. Phosphodiesterase inhibitors. British Journal of Pharmacology (2006) 147, S252–S257 Vezzosi D, et al. Phosphodiesterases in endocrine physiology and disease. European Journal of Endocrinology (2011) 165 177–188
  • 6. Boswell-Smith V, et al. Phosphodiesterase inhibitors. British Journal of Pharmacology (2006) 147, S252–S257 Vezzosi D, et al. Phosphodiesterases in endocrine physiology and disease. European Journal of Endocrinology (2011) 165 177–188
  • 7. Boswell-Smith V, et al. Phosphodiesterase inhibitors. British Journal of Pharmacology (2006) 147, S252–S257 Vezzosi D, et al. Phosphodiesterases in endocrine physiology and disease. European Journal of Endocrinology (2011) 165 177–188
  • 8. Boswell-Smith V, et al. Phosphodiesterase inhibitors. British Journal of Pharmacology (2006) 147, S252–S257 Vezzosi D, et al. Phosphodiesterases in endocrine physiology and disease. European Journal of Endocrinology (2011) 165 177–188